期刊文献+

肿瘤相关抗原及抗体在肝癌诊断中的研究进展 被引量:3

Research progress in tumor- associated antigen antibodies for diagnosis of liver cancer
下载PDF
导出
摘要 肝癌是全世界最常见的恶性肿瘤之一,虽然其治疗手段不断进步,但病死率仍居高不下。早期诊断可提高患者的生存时间,因此,亟须探索新的生物标志物以便及时诊断肝癌。当前研究的热点集中于肿瘤相关抗原(TAA)及对应的自身抗体来作为肿瘤血清学生物学标志,介绍了自身抗体的产生过程以及当前在肝癌组织中所发现的TAA组和抗-TAAs。此外,指出了这些新发现的自身抗体具有较高敏感性和特异性,将有助于肝癌的早期诊断。 Liver cancer is one of the most common malignant tumors in the world.The mortality of patients with liver cancer remains high e-ven with increasing progress in therapies.Early diagnosis is helpful for prolonging the survival of patients,so new biomarkers need to be ex-plored for timely diagnosis and treatment of liver cancer.The present research focuses on tumor-associated antigens (TAAs)and their cor-responding autoantibodies as serological biomarkers of liver cancer.The production of autoantibodies and the TAAs and anti-TAAs currently found in the liver cancer tissue are summarized.In addition,it is pointed out that these newly found autoantibodies have relatively high sen-sitivity and specificity for the early diagnosis of liver cancer.
出处 《临床肝胆病杂志》 CAS 2014年第6期573-576,共4页 Journal of Clinical Hepatology
关键词 肝肿瘤 抗原 肿瘤 自身抗体 综述 liver neoplasms antigens,neoplasm autoantibodies review
  • 相关文献

参考文献5

二级参考文献48

  • 1Wojciech Blonski,David S Kotlyar,Kimberly A Forde.Non-viral causes of hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(29):3603-3615. 被引量:28
  • 2冷爱民,张桂英.CA125在肝硬化患者中的前瞻性观察[J].世界华人消化杂志,2004,12(7):1759-1760. 被引量:14
  • 3Chaur-Shine Wang,Chin-Lin Lin,Hsi-Chang Lee,Kuan-Yang Chen,Ming-Feng Chiang,Hung-Sheng Chen,Tsung-Jung Lin.Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(39):6115-6119. 被引量:19
  • 4曹艳雪,安平,卞丽,吕丹,尹波,张丽瑶.慢性重型肝炎患者血清CA199和CA125检测的临床意义[J].实用肝脏病杂志,2006,9(6):354-355. 被引量:8
  • 5Ferlay J,Shin HR,Bray F,et al.GLOBOCAN 2008 v1.2,Cancer Incidence and Mortality Worldwide:IARC Cancer-Base No.10[Internet].Lyon,France:International Agencyfor Research on Cancer;2010.Available from:http://globo-can.iarc.fr,accessed on 29/01/2012.
  • 6Li Y,Yang H,Cao J.Association between alcohol consump-tion and cancers in the Chinese population-a systematic re-view and meta-analysis[J].PLoS One,2011,6(4):e18776.
  • 7Wang C,Wang X,Gong G,et al.Increased risk of hepato-cellular carcinoma in patients with diabetes mellitus:A sys-tematic review and meta-analysis of cohort studies[J].IntJ Cancer,2012,130(7):1639-1648.
  • 8Tao LY, Cai L, He XD, et al. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma[J].Am Surg, 2010, 76 (11): 1210-1213.
  • 9Chang K, Lu SN. Incidence and associated risk factors ofhepatocellular carcinoma in a dural hepatitis B and C virus endemic area~ a surveillance study [J]. Kaohsiung J Med Sci, 2011, 27 (3): 85-90.
  • 10Ashraf MK, Ferdous A, Hossein P, et al. The role of mutations in core protein of hepatitis B virus in liver fibrosis [J]. VirolJ, 2009, 6 (1): 209-218.

共引文献119

同被引文献25

  • 1Seung Oe Lim,Sung Gyoo Park,Jun-Hi Yoo,Young Min Park,Hie-Joon Kim,Kee-Taek Jang,Jae Won Cho,Byung Chul Yoo,Gu-Hung Jung,Cheol Keun Park.Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules[J].World Journal of Gastroenterology,2005,11(14):2072-2079. 被引量:62
  • 2Hanna T P,Shafiq J,Delaney G P,et al.The population benefit of radiotherapy for cervical cancer:local control and survival estimates for optimallyutilized radiotherapy and chemoradiation[J].Radiother Oncol,2015,114(3):389-394.
  • 3Heo C K,Bahk Y Y,Cho E W.Tumor associated autoantibodies as diagnostic and prognostic biomarker[J].BMB Rep,2012,45(12):677-685.
  • 4Zaenker P,Ziman M R.Serologic autoantibodies as diagnostic cancer biomarkers-a review[J].Cancer Epidemiol Biomarkers Prev,2013,22(12):2161-2181.
  • 5Liu W,De La Torre I G,Gutiérrez-Rivera M C,et al.Detection of autoantibodies to multiple tumor-associated antigens(TAAs)in theimmunodiagnosis of breast cancer[J].Tumour Biol,2015,36(2):1307-1312.
  • 6Fernández M F,Maroun M C.Autoantibodies in breast cancer[J].Adv Clin Chem,2014,64(1):221-240.
  • 7Kuglik P,Kasikova K,Smetana J,et al.Molecular cytogenetic analyses of h TERC(3q26)and MYC(8q24)genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervicalintraepithelial neoplasia and cervical carcinomas[J].Neoplasma,2015,62(1):130-139.
  • 8Albihn A,Johnsen J I,Henriksson M A.MYC in oncogenesis and as a target for cancer therapies[J].Adv Cancer Res,2010,107(4):163-224.
  • 9Xu Y W,Peng Y H,Chen B,et al.Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma[J].Am J Gastroenterol,2014,109(1):36-45.
  • 10Xu Y,Jin Y,Liu L,et al.Study of circulating Ig G antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer[J].FEBS Open Bio,2015,5(1):198-201.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部